Search
网站标志
PT-141
parameters1:
parameters2:
parameters3:
Bremelanotide PT141  is a compound under drug development by Palatin Technologies as a treatment for hemorrhagic shock and reperfusion injury. It functions by activating the melanocortin receptors MC1R and MC4R, to modulate inflammation and limiting ischemia. It was originally developed for use in treating sexual dysfunction but this application was temporarily discontinued in 2008, after concerns were raised over adverse side effects of increased blood pressure. Currently, Palatin is in negotiations with the FDA to resume Human Phase 2 studies using a new subcutaneous drug delivery system that appears to have little effect on blood pressure.
Products Search
脚注信息
China Top Testosterone Anabolic Steroid Supplier. Copyright ©2007- 2017 datubio.com. All Rights Reserved.

脚注栏目
Ѷ΢81˽̽˽̽˽̽˽̽˽̽ɳ˽̽˽̽ɶ˽̽˽̽Ϸ˽̽ͺ˽̽˽̽˽̽ϲ˽̽˽̽ൺ˽̽˽̽ʯׯ˽̫̽ԭ˽̽³ľ˽̽˽̽˾˽̽˽̽ݸ˽̽˽̽˽̽Ͼ˽̽人˽֣̽˽̽81